A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
Clinical trial NCT05450601 · COMPLETED
Trial details
- NCT number
- NCT05450601
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-12-11
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.